Scientific Session
Professional Development
Hanna Zembrzuska, MD
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Disclosure(s): AbbVie/Abbott: Grant/Research Support (Terminated); Allogene Therapeutics: Grant/Research Support (Ongoing); Amgen: Grant/Research Support (Ongoing); Argenx: Grant/Research Support (Ongoing); Artiva: Grant/Research Support (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Boehringer-Ingelheim: Grant/Research Support (Terminated); Century Therapeutics: Grant/Research Support (Ongoing); CRISPR Therapeutics: Grant/Research Support (Ongoing); Cullinan Therapeutics: Grant/Research Support (Ongoing); Genentech: Grant/Research Support (Ongoing); ImmPACT Bio: Grant/Research Support (Terminated); Janssen: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Priovant: Grant/Research Support (Terminated); Resolve Therapeutics: Grant/Research Support (Ongoing); ZuraBio: Grant/Research Support (Ongoing)